Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin A Howe

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolatesVirginia C Gould, Aki Okazaki, Robin A Howe, et al.
Biochimica Et Biophysica Acta|March 30, 2010
Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activityAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
Infection Control and Hospital Epidemiology|February 10, 2009
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureusMandy Wootton, Timothy R Walsh, Eleri M Davies, et al.
Journal of Clinical Microbiology|November 17, 2006
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptidesMandy Wootton, Alasdair P MacGowan, Timothy R Walsh, et al.
The Journal of Biological Chemistry|April 25, 2008
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptidesAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50Matthew B Avison, Peter M Bennett, Robin A Howe, et al.
Emerging Infectious Diseases|June 18, 2004
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRobin A Howe, Alastair Monk, Mandy Wootton, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2025
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'Sara E Boyd, Mandy Wootton, Robin A Howe, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidRobin A Howe, Mandy Wootton, Alan R Noel, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from IndiaLim S Jones, Mark A Toleman, Janis L Weeks, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolatesVirginia C Gould, Aki Okazaki, Robin A Howe, et al.
Biochimica Et Biophysica Acta|March 30, 2010
Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activityAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
Infection Control and Hospital Epidemiology|February 10, 2009
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureusMandy Wootton, Timothy R Walsh, Eleri M Davies, et al.
Journal of Clinical Microbiology|November 17, 2006
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptidesMandy Wootton, Alasdair P MacGowan, Timothy R Walsh, et al.
The Journal of Biological Chemistry|April 25, 2008
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptidesAyman Hawrani, Robin A Howe, Timothy R Walsh, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50Matthew B Avison, Peter M Bennett, Robin A Howe, et al.
Emerging Infectious Diseases|June 18, 2004
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRobin A Howe, Alastair Monk, Mandy Wootton, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2025
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'Sara E Boyd, Mandy Wootton, Robin A Howe, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidRobin A Howe, Mandy Wootton, Alan R Noel, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from IndiaLim S Jones, Mark A Toleman, Janis L Weeks, et al.
Pageof 3